glp-1 drug cost The of manufacturing anti-obesity drugs is low The GLP-1 Access Gap: Mapping
Description
New trends in adverse respiratory events from ASA Closed Claims Project
This is problematic as patients with raised ICP and IIH have existent clinically relevant cognitive deficits and drug therapy which exacerbates cognitive function further compromises cognition
Metformin was used as a comparator due to overlapping indications
doi: 10.3390/ijms21228704 [DOI] [PMC free article] [PubMed] [Google Scholar] 45
Chakhtoura M et al
Rare but serious risks, such as pancreatitis, must also be considered
